Compounding is the practice of preparing customized medications for individual patients
By closely monitoring how each patient responds to the medication, she can adjust the treatment plan as needed to ensure optimal results
These GLP-1 agonist medications are designed for those struggling with weight issues, offering a promising solution without requiring drastic changes in diet or lifestyle
A cardiovascular prognosis evaluation trial of semaglutide in the treatment of T2DM reported that administration of semaglutide reduced the cardiovascular prognostic risk (110)
Discussion Our data demonstrate that metformin rapidly increases plasma levels of GLP-1, but not GIP or peptide YY, even in the absence of oral glucose administration
Other GLP-1 Agonists : Combining Zepbound with other GLP-1 receptor agonists (Semaglutide, Liraglutide, or Dulaglutide) is generally not advised due to similar mechanisms of action and an increased risk of side effects.